D. Joshua

6.4k total citations
52 papers, 959 citations indexed

About

D. Joshua is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, D. Joshua has authored 52 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 18 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in D. Joshua's work include Multiple Myeloma Research and Treatments (26 papers), T-cell and B-cell Immunology (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). D. Joshua is often cited by papers focused on Multiple Myeloma Research and Treatments (26 papers), T-cell and B-cell Immunology (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). D. Joshua collaborates with scholars based in Australia, United States and Benin. D. Joshua's co-authors include John Gibson, Ross Brown, S Samuel Yang, P. Joy Ho, Derek N.J. Hart, H. Kronenberg, Narelle Woodland, Hayley Suen, Christian Bryant and Najah T. Nassif and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and International Journal of Cancer.

In The Last Decade

D. Joshua

51 papers receiving 918 citations

Peers

Countries citing papers authored by D. Joshua

Since Specialization

Citations

This map shows the geographic impact of D. Joshua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Joshua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Joshua more than expected).

Fields of papers citing papers by D. Joshua

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Joshua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Joshua. The network helps show where D. Joshua may publish in the future.

Co-authorship network of co-authors of D. Joshua

This figure shows the co-authorship network connecting the top 25 collaborators of D. Joshua. A scholar is included among the top collaborators of D. Joshua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Joshua. D. Joshua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade 2016 ·Leukemia ·Hayley Suen, Ross Brown, S Samuel Yang, Claire Weatherburn, P. Joy Ho, Narelle Woodland, Najah T. Nassif, Pasquale Barbaro, Christian Bryant, Derek N.J. Hart, John Gibson, D. Joshua	156
2	Phospho-flow detection of constitutive and cytokine-induced pSTAT3/5, pAKT and pERK expression highlights novel prognostic biomarkers for patients with multiple myeloma 2014 ·Leukemia ·Ross Brown, S Samuel Yang, Claire Weatherburn, John Gibson, P. Joy Ho, Hayley Suen, Derek N.J. Hart, D. Joshua	17
3	International Myeloma Working Group recommendations for global myeloma care 2013 ·Leukemia ·Heinz Ludwig, Jesús F. San Miguel, Meletios Α. Dimopoulos, Antonio Palumbo, (unknown), R Powles, Suzanne Lentzsch, (unknown), Jian Hou, Artur Jurczyszyn, Ken Romeril, Roman Hájek, Evangelos Terpos, Kazuyuki Shimizu, D. Joshua, Vânia Hungria, (unknown), Dina Ben‐Yehuda, Pia Sondergeld, Elena Zamagni, Brian G.M. Durie	131
4	Interferon-alpha in the treatment of multiple myeloma 2011 ·Research at the University of Copenhagen (University of Copenhagen) ·T. L. Khoo, D. Joshua, John Gibson, Annette Juul Vangsted	1
5	Characterisation and relevance of CD138‐negative plasma cells in plasma cell myeloma 2010 ·International Journal of Laboratory Hematology ·Scott A. Reid, S Samuel Yang, R.E. Brown, (unknown), Esther Aklilu, (unknown), Narelle Woodland, D. Joshua	36
6	DC in multiple myeloma immunotherapy 2004 ·Cytotherapy ·Cameron J. Turtle, Ross Brown, D. Joshua, Derek N.J. Hart	12
7	CMRF44+ Dendritic Cells from Peripheral Blood Stem Cell Harvests of Patients with Myeloma as Potential Cellular Vectors for Idiotype Vaccination 2003 ·Leukemia & lymphoma ·(unknown), Ross Brown, Alan Murray, Daniel Sze, Belinda Pope, John Gibson, Derek N.J. Hart, D. Joshua	3
8	CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilisation in multiple myeloma 2000 ·Bone Marrow Transplantation ·P. Dyson, Noemi Horvath, D. Joshua, (unknown), (unknown), Ross Brown, John Gibson, LB To	22
9	Multiple myeloma ‐ evolving concepts of biology and treatment 2000 ·Australian and New Zealand Journal of Medicine ·D. Joshua, John Gibson	2
10	Syngeneic stem cell transplantation for HIV‐related lymphoma 1999 ·British Journal of Haematology ·Philip Campbell, Harry Iland, John Gibson, D. Joshua	28
11	Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonal 1997 ·Bone Marrow Transplantation ·Belinda Pope, Ross Brown, John Gibson, D. Joshua	20
12	Role of alpha interferon in multiple myeloma 1997 ·Blood Reviews ·D. Joshua, Stephanie F. MacCallum, John Gibson	13
13	The Functional Phenotype of the Primitive Plasma Cell in Patients with Multiple Myeloma Correlates with the Clinical State 1997 ·Leukemia & lymphoma ·Belinda Pope, (unknown), John Gibson, (unknown), James S. Wiley, D. Joshua	13
14	Mechanisms of the escape phase of myeloma 1994 ·Blood Reviews ·D. Joshua, John Gibson, Ross Brown	11
15	Multiple Myeloma: Expression of Nucleoside Transporters on Malignant Plasma Cells and Their Relationship to Cellular Proliferation 1994 ·Leukemia & lymphoma ·(unknown), Ross Brown, Belinda Pope, Gary P. Jamieson, A. R. P. Paterson, John Gibson, James S. Wiley, D. Joshua	9
16	Serum thymidine kinase as a prognostic indicator for patients with multiple myeloma: results from the MRC (UK) V Trial 1993 ·British Journal of Haematology ·Ross Brown, D. Joshua, Margaret Nelson, John Gibson, Janet Dunn, I. C. M. Maclennan	17
17	A RANDOMISED TRIAL OF EMPIRICAL ANTIBIOTIC THERAPY IN FEBRILE NEUTROPENIC PATIENTS WITH HEMATOLOGICAL DISORDERS: CEFTAZIDIME VERSUS AZLOCILLIN PLUS AMIKACIN 1989 ·Australian and New Zealand Journal of Medicine ·John Gibson, (unknown), D. Joshua, G. A. R. Young, (unknown), R. Benn, (unknown), Harry Iland, P. C. Vincent, H. Kronenberg	13
18	IMMUNE HEMOLYSIS AFTER AN ABO MISMATCHED RENAL TRANSPLANT 1989 ·Australian and New Zealand Journal of Medicine ·Andrew C. Perkins, (unknown), John Gibson, D. Joshua, J. R. Johnson, H. Kronenberg	3
19	Gallium scanning in the management of mediastinal Hodgkin's disease 1989 ·European Journal Of Haematology ·(unknown), (unknown), D. Joshua, Andrew F. McLaughlin, John Gibson, Brian F. Hutton, John G. Morris, H. Kronenberg	49
20	Biology of multiple myeloma—host‐tumour interactions and immune regulation of disease activity 1988 ·Hematological Oncology ·D. Joshua	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact